Pszeudo-Bartter-szindróma kialakulása kapcsán felismert C1529G- és G3978A-mutációk együttese által okozott cisztás fibrosis

Translated title of the contribution: Pseudo-Bartter syndrome in a case of cystic fibrosis caused by C1529G and G3978A compound heterozygosity

Katalin Horvatovich, Mária Örkényi, Éva Bíró, Kálmán Pongrácz, P. Kisfali, G. Talián, V. Csöngei, L. Járomi, E. Sáfrány, Ferenc Harangi, E. Sulyok, B. Melegh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The 8-month-old patient was hospitalized after a few days of apathy and feeding difficulty with moderate exsiccation. Severe hypokalemia, hyponatremia, hypochloremia associated with alcalosis were found, which were accompanied by the decreased urinary electrolytes and elevated serum renin and aldosteron, therefore the condition corresponded to a pseudo-Bartter syndrome. The diagnosis of cystic fibrosis was arisen, which was established by the elevated sweat cloride levels. Sequencing of the 27 exons of the cystic transmembrane regulator gene two rare mutations were detected in compound heterozygous form: in the exon 10 a C1529G transversion, whereas in the exon 20 a G3978A transition was verified, both of them result in development of premature stopcodons (S466X and W1282X, respectively). Carriage of first mutation could be found in the asymptomatic mother, while the other one was identified in the father. In the proband and in the mother a G3341A mutation was also detected in exon 17, which causes an R1070Q amino acid change. However, this likely cannot associate with pathology since the existing premature stopcodon on the same allele does not allow synthesis of protein. These mutations have been described in combination with ΔF508 mutation, however, their simultaneous presence in the same subject has not been reported. During the one and half year follow-up the clinical picture appeared benign.

Original languageHungarian
Pages (from-to)325-328
Number of pages4
JournalOrvosi Hetilap
Volume149
Issue number7
DOIs
Publication statusPublished - Feb 17 2008

Fingerprint

Bartter Syndrome
Cystic Fibrosis
Exons
Mutation
Mothers
Apathy
Hypokalemia
Hyponatremia
Sweat
Regulator Genes
Renin
Fathers
Electrolytes
Alleles
Pathology
Amino Acids
Serum
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pszeudo-Bartter-szindróma kialakulása kapcsán felismert C1529G- és G3978A-mutációk együttese által okozott cisztás fibrosis. / Horvatovich, Katalin; Örkényi, Mária; Bíró, Éva; Pongrácz, Kálmán; Kisfali, P.; Talián, G.; Csöngei, V.; Járomi, L.; Sáfrány, E.; Harangi, Ferenc; Sulyok, E.; Melegh, B.

In: Orvosi Hetilap, Vol. 149, No. 7, 17.02.2008, p. 325-328.

Research output: Contribution to journalArticle

@article{f22bbfa39f4f42f89dbbd086b05b1c56,
title = "Pszeudo-Bartter-szindr{\'o}ma kialakul{\'a}sa kapcs{\'a}n felismert C1529G- {\'e}s G3978A-mut{\'a}ci{\'o}k egy{\"u}ttese {\'a}ltal okozott ciszt{\'a}s fibrosis",
abstract = "The 8-month-old patient was hospitalized after a few days of apathy and feeding difficulty with moderate exsiccation. Severe hypokalemia, hyponatremia, hypochloremia associated with alcalosis were found, which were accompanied by the decreased urinary electrolytes and elevated serum renin and aldosteron, therefore the condition corresponded to a pseudo-Bartter syndrome. The diagnosis of cystic fibrosis was arisen, which was established by the elevated sweat cloride levels. Sequencing of the 27 exons of the cystic transmembrane regulator gene two rare mutations were detected in compound heterozygous form: in the exon 10 a C1529G transversion, whereas in the exon 20 a G3978A transition was verified, both of them result in development of premature stopcodons (S466X and W1282X, respectively). Carriage of first mutation could be found in the asymptomatic mother, while the other one was identified in the father. In the proband and in the mother a G3341A mutation was also detected in exon 17, which causes an R1070Q amino acid change. However, this likely cannot associate with pathology since the existing premature stopcodon on the same allele does not allow synthesis of protein. These mutations have been described in combination with ΔF508 mutation, however, their simultaneous presence in the same subject has not been reported. During the one and half year follow-up the clinical picture appeared benign.",
keywords = "C1529G, Cystic fibrosis, G3341A, G3978A, R1070Q",
author = "Katalin Horvatovich and M{\'a}ria {\"O}rk{\'e}nyi and {\'E}va B{\'i}r{\'o} and K{\'a}lm{\'a}n Pongr{\'a}cz and P. Kisfali and G. Tali{\'a}n and V. Cs{\"o}ngei and L. J{\'a}romi and E. S{\'a}fr{\'a}ny and Ferenc Harangi and E. Sulyok and B. Melegh",
year = "2008",
month = "2",
day = "17",
doi = "10.1556/OH.2008.28239",
language = "Hungarian",
volume = "149",
pages = "325--328",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "7",

}

TY - JOUR

T1 - Pszeudo-Bartter-szindróma kialakulása kapcsán felismert C1529G- és G3978A-mutációk együttese által okozott cisztás fibrosis

AU - Horvatovich, Katalin

AU - Örkényi, Mária

AU - Bíró, Éva

AU - Pongrácz, Kálmán

AU - Kisfali, P.

AU - Talián, G.

AU - Csöngei, V.

AU - Járomi, L.

AU - Sáfrány, E.

AU - Harangi, Ferenc

AU - Sulyok, E.

AU - Melegh, B.

PY - 2008/2/17

Y1 - 2008/2/17

N2 - The 8-month-old patient was hospitalized after a few days of apathy and feeding difficulty with moderate exsiccation. Severe hypokalemia, hyponatremia, hypochloremia associated with alcalosis were found, which were accompanied by the decreased urinary electrolytes and elevated serum renin and aldosteron, therefore the condition corresponded to a pseudo-Bartter syndrome. The diagnosis of cystic fibrosis was arisen, which was established by the elevated sweat cloride levels. Sequencing of the 27 exons of the cystic transmembrane regulator gene two rare mutations were detected in compound heterozygous form: in the exon 10 a C1529G transversion, whereas in the exon 20 a G3978A transition was verified, both of them result in development of premature stopcodons (S466X and W1282X, respectively). Carriage of first mutation could be found in the asymptomatic mother, while the other one was identified in the father. In the proband and in the mother a G3341A mutation was also detected in exon 17, which causes an R1070Q amino acid change. However, this likely cannot associate with pathology since the existing premature stopcodon on the same allele does not allow synthesis of protein. These mutations have been described in combination with ΔF508 mutation, however, their simultaneous presence in the same subject has not been reported. During the one and half year follow-up the clinical picture appeared benign.

AB - The 8-month-old patient was hospitalized after a few days of apathy and feeding difficulty with moderate exsiccation. Severe hypokalemia, hyponatremia, hypochloremia associated with alcalosis were found, which were accompanied by the decreased urinary electrolytes and elevated serum renin and aldosteron, therefore the condition corresponded to a pseudo-Bartter syndrome. The diagnosis of cystic fibrosis was arisen, which was established by the elevated sweat cloride levels. Sequencing of the 27 exons of the cystic transmembrane regulator gene two rare mutations were detected in compound heterozygous form: in the exon 10 a C1529G transversion, whereas in the exon 20 a G3978A transition was verified, both of them result in development of premature stopcodons (S466X and W1282X, respectively). Carriage of first mutation could be found in the asymptomatic mother, while the other one was identified in the father. In the proband and in the mother a G3341A mutation was also detected in exon 17, which causes an R1070Q amino acid change. However, this likely cannot associate with pathology since the existing premature stopcodon on the same allele does not allow synthesis of protein. These mutations have been described in combination with ΔF508 mutation, however, their simultaneous presence in the same subject has not been reported. During the one and half year follow-up the clinical picture appeared benign.

KW - C1529G

KW - Cystic fibrosis

KW - G3341A

KW - G3978A

KW - R1070Q

UR - http://www.scopus.com/inward/record.url?scp=40049101151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40049101151&partnerID=8YFLogxK

U2 - 10.1556/OH.2008.28239

DO - 10.1556/OH.2008.28239

M3 - Article

C2 - 18258563

AN - SCOPUS:40049101151

VL - 149

SP - 325

EP - 328

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 7

ER -